British researchers have identified interleukin 36 (IL-36) as a druggable proinflammatory driver of psoriasis....
Up To Date
Latest News
French cancer drug encapsulation specialist Erytech Pharma SA wants to raise US$100m (€85m) in an IPO at...
As first gene therapy ever, AMT-130 has been granted FDA Orphan Drug status in Huntington’s Disease.
Promethera Biosciences and Shibuya collaborate to establish a breakthrough cell therapy manufacturing...
Cancer immunotherapy specialist Immatics Biotechnologies GmbH (Tuebingen, Germany) raised US$58m in a Series...